Schmilovitz-Weiss H - Search Results

1

Detection of HCV-RNA in paraffin-embedded liver biopsies from patients with autoimmune hepatitis.

Savage K, Dhillon AP, Schmilovitz-Weiss H, el-Batanony M, Brown D, Dusheiko G, Scheuer PJ. Savage K, et al. J Hepatol. 1995 Jan;22(1):27-34. doi: 10.1016/0168-8278(95)80256-8. J Hepatol. 1995. PMID: 7751584

2

Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease.

Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, Simmonds P. Dusheiko G, et al. Hepatology. 1994 Jan;19(1):13-8. Hepatology. 1994. PMID: 8276349

3

Viral markers in the treatment of hepatitis B and C.

Schmilovitz-Weiss H, Levy M, Thompson N, Dusheiko G. Schmilovitz-Weiss H, et al. Gut. 1993;34(2 Suppl):S26-35. doi: 10.1136/gut.34.2_suppl.s26. Gut. 1993. PMID: 7686114 Free PMC article. Review.

4

Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C.

Neuman MG, Schmilovitz-Weiss H, Hilzenrat N, Bourliere M, Marcellin P, Trepo C, Mazulli T, Moussa G, Patel A, Baig AA, Cohen L. Neuman MG, et al. Int J Hepatol. 2012;2012:231210. doi: 10.1155/2012/231210. Epub 2012 Feb 22. Int J Hepatol. 2012. PMID: 22530132 Free PMC article.

5

Interferon therapy for chronic HCV hepatitis: trick or treat?

Malnick SD, Schmilovitz-Weiss H. Malnick SD, et al. J Clin Gastroenterol. 1997 Jul;25(1):310-3. doi: 10.1097/00004836-199707000-00002. J Clin Gastroenterol. 1997. PMID: 9412909

6

Serum adipocyte fatty acid binding protein in liver transplant recipients and the metabolic syndrome.

Schmilovitz-Weiss H, Laish I, Levi Z, Monsselise Y, Harif Y, Braun M, Boaz M, Ben-Ari Z. Schmilovitz-Weiss H, et al. Ann Hepatol. 2012 May-Jun;11(3):343-9. Ann Hepatol. 2012. PMID: 22481453 Free article.

7

Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.

Neuman MG, Benhamou JP, Marcellin P, Valla D, Malkiewicz IM, Katz GG, Trepo C, Bourliere M, Cameron RG, Cohen L, Morgan M, Schmilovitz-Weiss H, Ben-Ari Z. Neuman MG, et al. Transl Res. 2007 Mar;149(3):126-36. doi: 10.1016/j.trsl.2006.11.002. Transl Res. 2007. PMID: 17320798

8

Lamivudine treatment for acute severe hepatitis B: a pilot study.

Schmilovitz-Weiss H, Ben-Ari Z, Sikuler E, Zuckerman E, Sbeit W, Ackerman Z, Safadi R, Lurie Y, Rosner G, Tur-Kaspa R, Reshef R. Schmilovitz-Weiss H, et al. Liver Int. 2004 Dec;24(6):547-51. doi: 10.1111/j.1478-3231.2004.0983.x. Liver Int. 2004. PMID: 15566503 Clinical Trial.

9

Excellent outcome of Lamivudine treatment in patients with chronic renal failure and hepatitis B virus infection.

Schmilovitz-Weiss H, Melzer E, Tur-Kaspa R, Ben-Ari Z. Schmilovitz-Weiss H, et al. J Clin Gastroenterol. 2003 Jul;37(1):64-7. doi: 10.1097/00004836-200307000-00016. J Clin Gastroenterol. 2003. PMID: 12811212

10

Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.

Weinstein T, Chagnac A, Boaz M, Ori Y, Herman M, Zevin D, Schmilovitz-Weiss H, Gafter U. Weinstein T, et al. Nephron Clin Pract. 2004;97(2):c67-72. doi: 10.1159/000078403. Nephron Clin Pract. 2004. PMID: 15218332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page